By Lana Pine | Published on June 19, 2025 4 min read People with diabetes who take glucagon-like peptide-1 (GLP-1) receptor agonists (such as Ozempic and Wegovy) may have more than twice the risk of developing a serious eye condition called neovascular age-related macular degeneration (nAMD) a leading cause of vision loss in older adults according to a large-scale study published in JAMA Ophthalmology
Read our full guide on how to spot melanoma on your body
Anti-obesity Medications for Long-Term Use There are currently four AOMs that produce an average of 5-15% total body weight loss and are FDA approved for long-term use: phentermine-topiramate, naltrexone-bupropion, liraglutide, and semaglutide (Table 1)
[1] A GLP-1 Weight Loss Pill can support weight management for suitable patients, but results depend on clinical suitability, dose, side effects, adherence, diet and physical activity
GLP-1 compounds (semaglutide, tirzepatide, retatrutide) cost slightly more due to synthesis complexity
Med Clin North Am 101:285